Android
iOS
Windows
Blackberry| LClose | 5.25 | Price | 5.30 |
|---|---|---|---|
| Change | 0.05 (0.95%) | Low | 5.30 |
| High | 5.30 | EPS | 3.00 |
| PE | 22.68 | Shares Outs. | 1,195,876,488 |
| 52WkHigh | 8.45 | 52WkLow | 3.45 |
| 50d Mov Avg | 5.11 | 200d Mov Avg | 5.30 |
| AvgDlyVol | 1,514,141.37 | 3MthChg | -0.30 (-5.36%) |
| 6MthChg | 0.30 (6.00%) | 12MthChg | -3.00 (-36.14%) |
| Div. Yield | 141.5094 | Risk Factor | 0.02576162 |
| Sector | Pharmaceuticals | ||
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 18,411,475.00 |
| Profit before taxation | 1,160,154.00 |
| Taxation (expense)/credit | -542,530.00 |
| Profit after tax | 617,624.00 |
| Transfer to revenue reserve | 617,624.00 |
| Profit attributable to: | |
| Owners of the company | 617,624.00 |
| Non-controlling interest | |
| Earnings per 50k share (k) | 52.00 |
| Net assets per 50k share (k) | 7.00 |
| Name | Title |
|---|---|
| Edmund Onuzo | Chairman of the Board |
| Jonathan Murray | Finance Director, Director |
| Seyi Adesomi | Head of Operations |
| Henry Akpoguma | Head of IT |
| Ayodeji Owadara | Manager, Compliance |
| Uchenna Uwechia | Head of Legal/Company Secretary |
| Dayanand Sriram | Managing Director, Director |
| T. Dayanand | General Manager, GSK Cx |
| Raphael Adebiyi | Finance Controller |
| Kayode Adebiyi | Sales Director |
| Kerry Alexander | Marketing Director |
| Adediran Aderemi | Head of Human Resources |
Chart Of The Day - ASI Chart Vs ASI Advance Decline Line (YTD) (10-Aug-2020 16:08:27.817) 
U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine 
[GLAXOSMITH]>>Notice of Meeting -<GLAXO SMITHKLINE CONSUMER NIG. PLC.>